Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PP405 in Adults With Androgenetic Alopecia
NCT06393452Phase 2Completed
- Sponsor
- Pelage Pharmaceuticals
- Start
- Jun 2024
- Primary completion
- Jul 2025
- Countries
- 1
01
Overview
A Phase 2 trial of PP405 topical vehicle gel in androgenetic alopecia (AGA), sponsored by Pelage Pharmaceuticals. Started Jun 2024; status: completed.
02
Drugs
PP405 topical vehicle gel
03
Conditions
androgenetic alopecia (AGA)
Beyond the preview
Go deeper on NCT06393452.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06393452.